Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients.
Lorena Martín-AguilarPol Camps-RenomCinta LleixàElba Pascual-GoñiJordi Díaz-ManeraRicardo Rojas-GarcíaNoemi De LunaEduard GallardoElena Cortés-VicenteLaia MuñozDaniel AlcoleaAlberto LleóCarlos CasasnovasChristian HomedesGerardo Gutiérrez-GutiérrezMaría Concepción Jimeno-MonteroJosé BercianoMaría José Sedano-TousTania García-SobrinoJulio Pardo-FernándezCeledonio Márquez-InfanteIñigo Rojas-MarcosIvonne Jericó-PascualEugenia Martínez-HernándezGermán Morís de la TassaCristina Domínguez-GonzálezIsabel IllaLuis Antonio Querol-GutiérrezPublished in: Journal of neurology, neurosurgery, and psychiatry (2020)
Baseline sNfL levels are increased in patients with GBS, are associated with disease severity and axonal variants and have an independent prognostic value in patients with GBS.